Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Tailored Supramarginal Resection in Glioblastoma Guided by Artificial Intelligence-based Recurrence Probability Maps. A Non-randomized Pilot Study

NCT05735171 is registered in ClinicalTrials.gov with Hospital del Rio Hortega as lead sponsor.

NCT NCT05735171
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05735171 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Tailored Supramarginal Resection in Glioblastoma Guided by Artificial Intelligence-based Recurrence Probability Maps. A Non-randomized Pilot Study
Lead sponsor
Hospital del Rio Hortega
Phase
Not applicable
Overall status
Completed
Start date
November 1, 2022
Completion date
December 1, 2025
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

glioblastoma